Key Takeaways Retatrutide (LY3437943) is Eli Lilly's investigational triple hormone receptor agonist, acting at GLP-1, GIP, and glucagon receptors
Risk of thyroid tumors with glucagon-like peptide-1 receptor agonists: a retrospective cohort study
The prescribing provider determines whether compounded medication is appropriate based on individual circumstances and medical judgment
Ingredients Water, Glycerin, Caprylic/Capric Triglyceride, Hydrogenated Polydecene, Cetearyl Alcohol, Butylene Glycol1,2-Hexanediol, Niacinamide, Cetearyl Olivate, Butyrospermum Parkii (Shea) Butter, Methyl Hydrogenated Rosinate, Squalane, Synthetic Beeswax, Propanediol, Glycereth-26Sorbitan Olivate, Polyglyceryl-2 Stearate, Diglycerin, Vinyl Dimethicone, Glyceryl Stearate, Stearyl Alcohol, Carbomer, Tromethamine, Macadamia Ternifolia Seed Oil, Sodium Polyacryloyldimethyl Taurate, Hydrogenated Lecithin, Retinol, Brassica Campestris (Rapeseed) Sterols, Ethylhexylglycerin, Adenosine Cholesterol, Polyglyceryl-10 Laurale, Hydrolyzed Gardenia Florida Extract, Hydrolyzed Malt Extract, Disodium EDTA, Hydrolyzed Viola Tricolor Extract, Phytosteryl/Behenyl/Octyldodecyl Lauroyl Glutamate, Sodium Hyaluronate, Ammonium Polyacryloyldimethyl Taurate, Hyaluronic Acid, Hydrolyzed Hyaluronic Acid, Aluminum/Magnesium Hydroxide Stearate, Pentaerythrityl Tetra-di-t-butyl, Hydroxyhydrocinnamate Trideceth-10, Potassium Cetyl Phosphate, Pancratium Maritimum Extract, Leontopodium Alpinum Callus Culture Extract, Chitosan, Glutathione, Tris(Tetramethylhydroxypiperidinol) Citrate Content 30 ml / 1.0 fl oz For Topical and Cosmetic Use Only
Clinical benefits include improved insulin sensitivity, lipid profiles, and cardiovascular outcomes associated with visceral fat reduction
These services often start above $400 in-clinic and can exceed $1,000 for higher dosages or mobile delivery
